Newsroom | 104239 results
Sorted by: Latest
-
Semtech Announces Third Quarter of Fiscal Year 2027 Conference Call
CAMARILLO, Calif.--(BUSINESS WIRE)--Semtech Announces Third Quarter of Fiscal Year 2027 Conference Call...
-
Quanterix Releases Financial Results for the Third Quarter of 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced financial results for the third quarter ended September 30, 2026. “We delivered higher than expected topline growth in the third quarter, with revenues up 6.3% sequentially, despite continued market softness. This first step in restoring growth reflects sequential improvement across all our businesses. The actions we initiated last quarter to improve commercia...
-
Trinseo Reports Third Quarter 2026 Financial Results
WAYNE, Pa.--(BUSINESS WIRE)--Trinseo (Pink Limited:TSEOF): Three Months Ended September 30, $millions, except per share data 2026 2025 Net Sales $ 779 $ 743 Net Loss (49 ) (110 ) Diluted EPS ($) (1.34 ) (3.05 ) Adjusted Net Loss* (2 ) (88 ) Adjusted EPS ($)* (0.05 ) (2.44 ) EBITDA* 10 26 Adjusted EBITDA* 51 30 Cash provided by (used in) operating activities 26 (22 ) Free Cash Flow* 15 (38 ) _______________________ *For a reconciliation of...
-
Motorcar Parts of America Reports Fiscal 2027 Second Quarter Results
LOS ANGELES--(BUSINESS WIRE)--Motorcar Parts of America, Inc. (Nasdaq: MPAA) today reported financial results for its fiscal 2027 second quarter ended September 30, 2026. Results reflect delayed customer orders and launches of new business awards, requiring revised guidance for the fiscal year. The company expects increased sales for the second half of the current fiscal year compared with the same period a year ago. Positive Drivers Approximately $60 Million in New Annualized Customer Business...
-
Delcath Systems Reports Third Quarter 2026 Results and Business Highlights
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial results and business highlights for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Results Total revenue of $35.1 million, compared with $20.6 million in the third quarter of 2025 HEPZATO KIT™ revenue of $32.7 million, compared to $19.3 million in the third quarter of 2025...
-
Spruce Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the third quarter ended September 30, 2026, and provided corporate updates. “We are executing with discipline as we complete the final steps toward our planned BLA submission for TA-ERT in December, which we believ...
-
Douglas Elliman Inc. to Host Third Quarter 2026 Results Conference Call
MIAMI--(BUSINESS WIRE)--Douglas Elliman Inc. (NYSE: DOUG) will conduct a conference call and webcast to discuss its third quarter 2026 results on Tuesday, November 10, 2026 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://join.eventcastplus.com/eventcastplus/douglas-elliman-third-quarter-earnings-call. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on November 10, 2026 through Novemb...
-
RB Global Reports Third Quarter 2026 Results
WESTCHESTER, Ill.--(BUSINESS WIRE)--RB Global, Inc. (NYSE & TSX: RBA, the “Company”, “RB Global”, “we”, “us”, or “our”) reported the following results for the three months ended September 30, 2026. "Our third-quarter results demonstrate the strength of RB Global's marketplace and the consistent execution of our teams to deliver solid topline and bottom-line growth," said Jim Kessler, CEO of RB Global. “We remain committed to gaining market share, delivering strong growth across all our busi...
-
Coincheck Reports Financial Results for Second Quarter of Year Ending March 31, 2027
AMSTERDAM--(BUSINESS WIRE)--Coincheck Group N.V. (NASDAQ: CNCK) (“Coincheck Group” or the “Company”), a Dutch public limited liability company that provides digital asset trade execution, custody, staking and asset management services, today reported financial results for the second quarter of the fiscal year ending March 31, 2027 (“fiscal 2027”). References to “fiscal 2026” mean the fiscal year ended March 31, 2026. Financial Highlights:1 Certain Year-Over-Year Highlights Total revenue for the...
-
Neurogene Reports Third Quarter 2026 Financial Results and Highlights Recent Updates
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced third quarter 2026 financial results and highlighted recent corporate updates. “During the third quarter, we continued to execute across all aspects of our NGN-401 program as we advance toward potential commercialization,” said Rachel McMinn, Ph.D., Founder and Chief Executive Officer...